Skip to menu Skip to content Skip to footer

2005

Conference Publication

Population pharmacokinetics: A way forward for optimal dosage prediction in children

Tett, S. E. (2005). Population pharmacokinetics: A way forward for optimal dosage prediction in children. 10th International Congress of Pediatric Laboratory Medicine, Singapore, 3-6 Sept. 2005. Singapore: IAPLM.

Population pharmacokinetics: A way forward for optimal dosage prediction in children

2005

Journal Article

Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural Australia

Cutts, C. and Tett, S.E. (2005). Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural Australia. Australian Journal of Rural Health, 13 (1), 43-50. doi: 10.1111/j.1440-1854.2004.00644.x

Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural Australia

2005

Conference Publication

Cystatin C to estimate renal function: A meta-analysis

Roos, J. F., Doust, J., Tett, S.E. and Kirkpatrick, C. M. J. (2005). Cystatin C to estimate renal function: A meta-analysis. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.

Cystatin C to estimate renal function: A meta-analysis

2005

Journal Article

Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors

Behan, K., Cutts, C. and Tett, S. E. (2005). Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors. European Journal of Clinical Pharmacology, 61 (1), 55-58. doi: 10.1007/s00228-004-0865-6

Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors

2005

Journal Article

Pharmacokinetic considerations relating to tacrolimus dosing in the elderly

Staatz, C. E. and Tett, S. E. (2005). Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs & Aging, 22 (7), 541-557. doi: 10.2165/00002512-200522070-00001

Pharmacokinetic considerations relating to tacrolimus dosing in the elderly

2005

Conference Publication

Consumers on the map: Australia's QUM map

Tett, S. E., Roughead, E. E., Monteith, G. R. and Kirkpatrick, C. M. J. (2005). Consumers on the map: Australia's QUM map. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, Qld, Australia, 10-13 November, 2005. Brisbane, Qld, Australia: Event Planners Australia.

Consumers on the map: Australia's QUM map

2005

Conference Publication

How much, how often, how long?

Tett, S. E. (2005). How much, how often, how long?. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.

How much, how often, how long?

2004

Journal Article

Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration

DelDot, Megan E., Lipman, Jeffrey and Tett, Susan E. (2004). Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration. British Journal of Clinical Pharmacology, 58 (3), 259-268. doi: 10.1111/j.1365-2125.2004.02143.x

Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration

2004

Journal Article

Perceptions around concordance - focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners

Bajramovic, Jasmina, Emmerton, Lynne and Tett, Susan E. (2004). Perceptions around concordance - focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expectations, 7 (3), 221-234. doi: 10.1111/j.1369-7625.2004.00280.x

Perceptions around concordance - focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners

2004

Journal Article

Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia

Atcheson, Bronwyn A., Taylor, Paul J., Kirkpatrick, Carl M. J., Duffull, Stephen B., Mudge, David W., Pillans, Peter I., Johnson, David W. and Tett, Susan E. (2004). Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Therapeutic Drug Monitoring, 26 (3), 284-286. doi: 10.1097/00007691-200406000-00011

Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia

2004

Journal Article

A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation

Staatz, Christine E., Taylor, Paul J., Lynch, Stephen V. and Tett, Susan E. (2004). A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Liver Transplantation, 10 (4), 506-512. doi: 10.1002/lt.20065

A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation

2004

Conference Publication

Working with health professionals and consumers in tandem: What is the evidence?

Tett, S.E (2004). Working with health professionals and consumers in tandem: What is the evidence?. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service.

Working with health professionals and consumers in tandem: What is the evidence?

2004

Conference Publication

Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, Australia

Nissen, L. M., Cooke, C., Sketris, I. and Tett, S.E. (2004). Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, Australia. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x

Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, Australia

2004

Journal Article

Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection

Atcheson, Bronwyn, Taylor, Paul J., Mudge, David W., Johnson, David W., Pillans, Peter I. and Tett, Susan E. (2004). Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. Journal of Chromatography B, 799 (1), 157-163. doi: 10.1016/j.jchromb.2003.10.033

Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection

2004

Conference Publication

Sample medication: What do Australian general practitioners think?

Nissen, L. M., Hall, K. H. and Tett, S. E. (2004). Sample medication: What do Australian general practitioners think?. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service.

Sample medication: What do Australian general practitioners think?

2004

Conference Publication

An argument for dose individualisation of sirolimus in renal transplant recipients

Dansirikul, C., Duffull, S. B., Morris, R. and Tett, S.E. (2004). An argument for dose individualisation of sirolimus in renal transplant recipients. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.v31_i11_abs.x

An argument for dose individualisation of sirolimus in renal transplant recipients

2004

Journal Article

A perspective on Australia's national medicines policy

Tett, S. E. (2004). A perspective on Australia's national medicines policy. Canadian Journal of Clinical Pharmacology, 11 (1), e28-e38. doi: 10.22374/jptcp.v11i1.62

A perspective on Australia's national medicines policy

2004

Conference Publication

How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reporting

Chan, V. and Tett, S. E. (2004). How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reporting. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service.

How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reporting

2004

Conference Publication

Bayesian population pharmacokinetic analysis of sirolimus

Dansirikul, C., Friberg, L. E., Duffull, S. B., Morris, R. and Tett, S.E. (2004). Bayesian population pharmacokinetic analysis of sirolimus. Population Approach Group in Europe - Thirteenth Meeting (PAGE), Uppsala University, Sweden, 17-18 June 2004. Sweden: Uppsala University.

Bayesian population pharmacokinetic analysis of sirolimus

2004

Journal Article

Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography

Chan, V., Charles, B. G. and Tett, S. E. (2004). Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography. Journal of Chromatography B-analytical Technologies In The Biomedical And Life Sciences, 803 (2), 331-335. doi: 10.1016/j.jchromb.2004.01.016

Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography